Why register with MediGuard?

We are a free monitoring service designed for patients like you who
want to be in the driver seat of your medical treatment. We have a
community of more than 2.6 million members and offer the services
below.

Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

FDA Warns about Risk of Developing Rare Type of Pneumonia During Treatment With Cubicin
Today, the U.S. Food and Drug Administration (FDA) notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin). Cubicin is an intravenous antibiotic indicated for use in treatment of serious skin infections and bloodstream infections. Eosinophilic pneumonia is a rare but serious condition where a type of white blood cell (eosinophil) fills the lungs. Symptoms of eosinophilic pneumonia include fever, cough, shortness of breath, and difficulty breathing. Eosinophilic pneumonia may lead to serious lung complications and can be fatal if not quickly recognized and managed by doctors.
For more information, please visit:
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm220273.htmLearn More

Bausch + Lomb Recalls PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 Soft Gel
Bausch + Lomb is conducting a voluntary recall of its PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 soft gels, only available in the United States. Bausch + Lomb has issued this recall based on a small number of reports of difficulty swallowing or a choking sensation when taking the soft gel. These reports were mainly from people age 70 and older.
The formulation of PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 is safe. Many consumers can comfortably swallow the supplement. However, Bausch + Lomb plans to redesign the soft gel into a smaller size so that consumes have a supplement which is easier to swallow.
The recalled PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 soft gels are packaged in 60 count bottles and labeled with the lot numbers 0923BK103, 0924BK103, 0924BK103A, 0925BK103A, 0926BK103A, 0927BK103A, 0928BK103A, 0929BK103A, or 0930BK103A.
The PreserVision Eye Vitamin AREDS 2 Formula with Omega 3 is the only supplement affected in the recall. All other PreserVision and Ocuvite supplements, soft gels and tablets, remain on the market.
For more information, please visit:
http://www.bausch.com/en_US/corporate/corpcomm/general/recall_information.aspx and
http://www.fda.gov/Safety/Recalls/ucm220353.htmLearn More

DISCLAIMER: MediGuard is not intended to be a substitute for
professional medical advice. MediGuard cannot and does not take into
consideration every possible interaction or account for individual
responses to medicine.
Different individuals may respond to medication in different ways. The
absence of a warning for a given drug or drug combination in no way
should be construed to indicate that the drug or drug combination is
safe, effective, or appropriate for any given patient. Always seek the
advice of a qualified health provider with any questions you may have
before making any changes to your treatment. The use of the MediGuard
site and its content is at your own risk. The MediGuard site and the
information contained in it is intended for users in the United States and information in other countries may be different.